BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Drug Development

  VBL Therapeutics Release: Phase I/II Data of VB-111 Demonstrate Anti-Tumor Effects With Increase in Overall Survival With This Anti-Angiogenic Gene Therapy, in Patients With Recurrent Glioblastoma Multiforme

  June 3, 2013

   · 

  1 min read
• Fuse Science, Inc. CEO Interviewed by the Stock Radio

  June 3, 2013

   · 

  2 min read
• Genetown

  First Clinical Data Presented with IMGN853, ImmunoGen, Inc.’s Potential New Therapy for Ovarian and Other Cancers

  June 3, 2013

   · 

  1 min read
• BioMidwest

  Patterson Companies Announces June 2013 Investor Conference Schedule

  June 3, 2013

   · 

  1 min read
• IPG to Showcase IPG PathFinder 360™ at AHIP’s 2013 Institute

  June 3, 2013

   · 

  1 min read
• Deals

  Hyperion Therapeutics Acquires Worldwide Rights to BUPHENYL

  June 3, 2013

   · 

  1 min read
• Drug Development

  EXINI and Active Biotech AB Present Impact of Tasquinimod on Bone Metastases as Measured by Bone Scan Index (BSI)

  June 3, 2013

   · 

  1 min read
• Drug Development

  StemCells Inc.'s Spinal Cord Injury Trial Approved by Health Canada

  June 3, 2013

   · 

  1 min read
• BioCapital

  FDA and Device Companies Butt Heads on Overseas Trial Proposal

  June 3, 2013

   · 

  1 min read
• FDA

  Cochlear Americas Get FDA Approval for Aqua Accessory

  June 3, 2013

   · 

  3 min read